RecruitingNCT02815683

Bronchoscopic EmphysemA Treatment in THE NetherLands

Bronchoscopic Lung Volume Reduction Treatment in Clinical Practice: Introduction and Implementation in The Netherlands and Evaluation of a National Database


Sponsor

University Medical Center Groningen

Enrollment

500 participants

Start Date

Sep 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

Rationale: New bronchoscopic treatments for emphysema have shown promise in clinical trials, improving lung function, exercise capacity and possibly survival and are now being adopted by a number of centres in the Netherlands. It is important to ensure that the benefits seen in clinical trials are in fact reflected in clinical practice and that the best use of this early 'real world' experience is made to optimise the development and use of these novel therapies. Overall objective: to develop a national database to record bronchoscopic lung volume reduction procedures for patients with emphysema. This is desirable for audit purposes but will also be an important resource for research both in gathering data and in facilitating collaborations.


Eligibility

Inclusion Criteria1

  • Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves.

Locations(2)

University Medical Center Groningen

Groningen, Netherlands

Maastricht University Medical Center

Maastricht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02815683


Related Trials